StonvexLoading…
StonvexStonvexStonvexCore line items from RDVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $25.83M | $90.25M | $66.86M | $43.78M |
Operating Income | $5.44M | $13.14M | $11.54M | $6.96M |
Net Income | $4.39M | $13.15M | $10.34M | $6.13M |
EPS (Diluted) | $0.30 | $0.91 | $0.71 | $0.42 |
Total Assets | $112.63M | $112.01M | $112.07M | $104.83M |
Total Liabilities | $8.11M | $11.09M | $10.34M | $8.63M |
Cash & Equivalents | $43.45M | $43.56M | $45.35M | $38.85M |
Free Cash Flow OCF − CapEx | $6.52M | $28.79M | $22.22M | $12.24M |
Shares Outstanding | 14.11M | 14.15M | 13.97M | 13.98M |